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Introduction
Coronaviruses are single-stranded positive-sense 
Ribonucleic Acid (RNA) viruses, with the capacity 
for rapid mutation and recombination. They are 
known to cause respiratory or intestinal infections in 
humans and animals. Moreover, acute respiratory 
infections including influenza, respiratory syncytial 
and bacterial pneumonia are tr iggers for 
cardiovascular diseases and, on the other hand, the 
underlying cardiovascular disorders are usually 
associated with comorbidities, which may increase 
tie incidence and severity of infectious disease (1-
3).
Cardiovascular complications associated with the 
coronavirus infection were described since 
infections with severe acute respiratory coronavirus 
(SARS-CoV) and recently with severe acute 
respiratory coronavirus type 2(SARS-CoV-2). The 
later generate the clinical pattern defined as 
Coronavirus disease 2019 (COVID-19) , described 
in the first time in December 2019 in Wuhan, Hubei 
province, China. After that, there were mentioned 
direct effects of the virus and the consequences 
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Abstract
Introduction: Coronavirus disease 2019 (COVID-19) fatal outcomes have been associated with 
multiple cardiovascular risk factors. In new epidemic areas, such as Latin America, there is a lack 
of studies about this. Objectives: To evaluate demographic data, signs and symptoms during 
emergency arrival, prevalence of  cardiovascular risk factors, laboratory and ECG findings  and 
their influence in mortality,  in a retrospective cohort of patients in a national reference hospital of 
Lima, Peru. Methods: Review the clinical records of the patients attended at Hospital Rebagliati 
Hospital during March 6th and April 30th, 2020, using  rRT-PCR was used for the detection of the 
RNA of SARS-CoV-2 following the protocol Charité, Berlin, Germany, from nasopharyngeal 
swabs at the National Institute of Health. Bivariate analysis and multivariate analysis using logistic 
regression was done. Values of p < 0.05 were considered significant for all analyses. Results: 
One hundred six hospitalized patients were evaluated. The mean age of patients was 61.58 years 
(SD 16.81). Cardiovascular risk factors among them were hypertension (46.2%), diabetes 
(28.3%), and obesity (28.3%), among others. Fifty-six patients died (52.8%). Mortality associated 
factors at the multivariate analysis were arterial hypertension (OR=1.343, 95% 1.089-1.667), 
myocardial injury (OR=1.303, 95% 1.031-1.642), and mechanical ventilation (OR 1.262, 95% 
1.034-1.665), as associated factors. Conclusion: Cardiovascular risk factors and cardiovascular 
signs or symptoms are common during emergency arrival in patients with COVID-19. Arterial 
hypertension, myocardial injury and mechanical ventilation were associated with mortality in 
multivariate analysis, as observed in other regions of the world. 
Keywords: COVID-19, SARS-CoV-2, risk factors, outcomes, cardiovascular, Latin America.
Resumen
Introducción: Los desenlaces fatales de la enfermedad por coronavirus 2019 (COVID-19) se 
han asociado con múltiples factores de riesgo cardiovascular. En nuevas áreas epidémicas, 
como América Latina, faltan estudios al respecto. Objetivos: Evaluar datos demográficos, signos 
y síntomas durante la ingreso a emergencia, prevalencia de factores de riesgo cardiovascular, 
hallazgos de laboratorio y ECG y su influencia en la mortalidad, en una cohorte retrospectiva de 
pacientes en un hospital nacional de referencia de Lima, Perú. Métodos: Se revisaron las 
historias clínicas de los pacientes atendidos en el Hospital Nacional Edgardo Rebagliati durante 
los días 6 de marzo y 30 de abril de 2020, se utilizó rRT-PCR para la detección del ARN del SARS-
CoV-2 siguiendo el protocolo Charité, Berlín, Alemania de hisopos nasofaríngeos en el Instituto 
Nacional de Salud. Se realizó análisis bivariado y análisis multivariado mediante regresión 
logística. Los valores de p <0,05 se consideraron significativos para todos los análisis. 
Resultados: Se evaluaron ciento seis pacientes hospitalizados. La edad media de los pacientes 
fue de 61,58 años (DE 16,81). Los factores de riesgo cardiovascular entre ellos fueron 
hipertensión (46,2%), diabetes (28,3%) y obesidad (28,3%), entre otros. Fallecieron 56 pacientes 
(52,8%). Los factores asociados a la mortalidad en el análisis multivariado fueron hipertensión 
arterial (OR = 1.343, 95% 1.089-1.667), lesión miocárdica (OR = 1.303, 95% 1.031-1.642) y 
ventilación mecánica (OR 1.262, 95% 1.034-1.665), como factores asociados. Conclusión: Los 
factores de riesgo cardiovascular y los signos o síntomas cardiovasculares son comunes durante 
la llegada de emergencia en pacientes con COVID-19. La hipertensión arterial, la lesión 
miocárdica y la ventilación mecánica se asociaron con la mortalidad en el análisis multivariado, 
como se observó en otras regiones del mundo.
Palabras clave: COVID-19, SARS-CoV-2, factores de riesgo, Desenlaces, cardiovascular, 
Latinoamerica.
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associated with the host immune response (1,4-8).
Cardiovascular compromise in patients with 
COVID-19 has not been well studied because data 
is scarce. However, there were described cases of 
myocardial injury, myocarditis, thromboembolic 
disease, arrhythmias, among others. But there is no 
information about the long-term consequences of 
this disease (9-26).
Edgardo Rebagliati Martins national hospital is the 
largest hospital of the Peruvian social security 
(formal workers that represent the 30% of the total 
Peruvian population), with 2,000 hospital beds and 
is considered as a national reference center for 
patients with COVID-19 and concentrate a higher 
quantity of severe cases associated with this clinical 
condition (19).
The objectives of the present study are to describe 
the prevalence of cardiovascular risk factors in the 
selected population, to evaluate the clinical 
findings, laboratory and electrocardiographic data, 
and describe the evolution of patients, taking into 
count the presence of some cardiovascular risk 
factors.
Methods
An observational, retrospective study of a cohort of 
patients with COVID-19 who need medical 
attention, was carried out in the adult emergency 
service of Hospital Nacional Edgardo Rebagliati 
Martins- EsSalud, located in the district of Jesus 
María in Lima-Perú. This service accounts for 180 
beds and realizes 164,370 medical attentions per 
year and 22,883 admissions per day in patients over 
14 years of age with a public health insurance 
system. 
Patients considered for this study were those with a 
clinical diagnostic of COVID-19 and confirmed by 
molecular testing, RT-PCR, from nasopharyngeal 
swabs, attended and hospitalized between March 
6th and April 30th of 2020, in the Hospital Rebagliati. 
Only patients with confirmed pulmonary lesions by 
CT scan and oxygen saturation level below 93% 
were hospitalized due to a higher demand for health 
care services in Peruvian public hospitals. There 
were excluded patients transferred to other health 
centers and patients that arrive without vital signs. 
We obtained demographic data (age, gender), 
cardiovascular risk factors (hypertension, Diabetes, 
obesity), history of previous cardiovascular 
disease, time of symptoms, symptoms and signs 
during emergency arrival, prevalence of myocardial 
injury, Electrocardiographic (ECG) findings, time of 
hospital ization, prevalence of mechanical 
ventilation and evolution, from electronic clinical 
report of patients during hospitalization.
A twelve-lead ECG was recorded and evolution of 
troponin values were registered, considering the 
highest value of troponin during the evolution, and 
the diagnosis of myocardial injury if this value 
exceeds 99th percentile of the laboratory range 
validated in the hospital.
We used SPSS 24.0 for statistical analysis that 
includes descriptive, bivariate analysis, and 
multivariate analysis (binary logistic regression). A 
p-value of less than 0.05 was considered 
statistically significant (95% confidence level).
The project was authorized for the emergency 
department and the Ethics and investigation 
committee for COVID-19 in EsSalud. The principle 
of confidentiality was guaranteed. Informed consent 
was not obtained because the source document 
was secondary (an electronic clinical record), and 
there was not any intervention for the patient. 
Results
One hundred six hospitalized patients were 
evaluated.  47 (44.34%) had more than 65 years of 
age and  81 (76.4%) were of male gender (Table 1). 
Cardiovascular risk factors among the study 
population were hypertension (46.2%), diabetes 
(28.3%), and obesity (28.3%). Sixteen patients 
(6.76%) report a previous cardiovascular disease 
(15.09%).
They arrived in the emergency room with more than 
seven days of symptoms: 7.35 (SD 3.53). 54.71% 
with more than seven days (Table 1).
Table 1. Clinical , demographical and 




<30 years 3 2.83
30-64 years 56 52.83
65-84 years 39 36.79
?85 years 8 7.55
Gender distribution
Male  81 76.4
Female 25 23.6




Previous history of cardiovascular 
disease 16 15.1
Time of symptoms at arrival
Less than 3 days 16 15.1
From 3 to 7 days 32 30.2
More than 7 days 58 54.7
The most frequent signs and symptoms during 
emergency arrival (Figure 1) were dyspnea 
(82.07%), tachycardia (35.8%), and higher levels of 
blood pressure (17.9%). Myocardial injury was 
found in 40 of 79 patients tested (50.6%). The 
median value of troponin value was 0.033 (IQR 
0.047).
Figure 1. Clinical findings at the ER income
ECG finding N %
Normal ECG 22 55
Arrythmia 11 27.5
-atrial fibrillation 4 10
-sinus bradycardia 2 5
-sinus tachycardia 1 2.5
-First degree AV block 2 5
-Third degree AV block 1 2.5
-Ventricular extrasystolia 1 2.5
Left ventricular hypertrophy 3 7.5
Acute ischemia 3 7.5
In 40 patients, 12-lead ECG recorded was obtained. 
22 (55%) had an ECG without specific alterations. In 
the rest of the patients, some arrhythmias and other 
ECG changes were documented (Table 2).
Table 2. ECG findings
The median of hospitalization was eight days (IQR 
12.25). In 64.15% of cases, the time of admission 
was higher than seven days, and in 17 patients 
(16.04%) was more top than 30 days. 22 (20.75%) 
patients entered to invasive mechanical ventilation. 
Fifty-six patients died, which corresponds to a 
mortality rate of 52.8% (Figure 2). Mortality 
associated factors  were age more than 65 years, 
myocardial injury, mechanical ventilation, and 
arterial hypertension were associated with 
statistical differences in bivariate analysis. In the 
mul t i var ia te  ana lys is ,  we found ar te r ia l 
hypertension, myocardial injury, and mechanical 
ventilation as associated factors (Table 3).
Discussion
The present report describes cardiovascular risk 
factors and some clinical, laboratory, and electro-
cardiography findings in a group of patients 
hospitalized for moderate to severe COVID-19 
attended in a national reference hospital of social 
security.
Although multiple studies have reported the clinical 
findings in COVID-19,20-27 and some of the 
associated risk factors (25,26), few in Latin America 
have shown the relationship between cardiovas-
cular risk factors and fatal outcomes (26).
The prevalence of cardiovascular risk factors was 
similar to CDC and Italian reports (from the 
Lombardy region) for arterial hypertension (46.2%) 
and higher in comparison with reports of Chinese 
hospitals (30.5%). A similar phenomenon occurs for 
diabetes found in 28.3%, which was identical to the 
CDC report and superior to Italian and Chinese 
reports, 17.3% and 14% respectively (3,5,6,16). But 
the prevalence of cardiovascular risk factors and 
previous cardiovascular disease is higher in 
patients with severe COVID-19 and in patients who 
died due to COVID-19 (21).
However, these prevalences in hospitalized 
patients with COVID-19 were superior to the 
Peruvian TORNASOL report, which corresponds to 
a national evaluation for hypertension and other 
cardiovascular risk factors, carried out in 2011, 
ISSN 2616 - 6097, Rev Peru Investig Salud, 2021, 5(3), july - september: 195-200
196 Valenzuela GV, Rodríguez-Morales AJ, Mamani R, Ayala R, Pérez K, Sarmiento C, Calcino J, García L, Amado J
ISSN 2616 - 6097, Rev Peru Investig Salud, 2021, 5(3), july - september: 195-200
197COVID-19 and Cardiovascular risk factors in Peru
associated with the host immune response (1,4-8).
Cardiovascular compromise in patients with 
COVID-19 has not been well studied because data 
is scarce. However, there were described cases of 
myocardial injury, myocarditis, thromboembolic 
disease, arrhythmias, among others. But there is no 
information about the long-term consequences of 
this disease (9-26).
Edgardo Rebagliati Martins national hospital is the 
largest hospital of the Peruvian social security 
(formal workers that represent the 30% of the total 
Peruvian population), with 2,000 hospital beds and 
is considered as a national reference center for 
patients with COVID-19 and concentrate a higher 
quantity of severe cases associated with this clinical 
condition (19).
The objectives of the present study are to describe 
the prevalence of cardiovascular risk factors in the 
selected population, to evaluate the clinical 
findings, laboratory and electrocardiographic data, 
and describe the evolution of patients, taking into 
count the presence of some cardiovascular risk 
factors.
Methods
An observational, retrospective study of a cohort of 
patients with COVID-19 who need medical 
attention, was carried out in the adult emergency 
service of Hospital Nacional Edgardo Rebagliati 
Martins- EsSalud, located in the district of Jesus 
María in Lima-Perú. This service accounts for 180 
beds and realizes 164,370 medical attentions per 
year and 22,883 admissions per day in patients over 
14 years of age with a public health insurance 
system. 
Patients considered for this study were those with a 
clinical diagnostic of COVID-19 and confirmed by 
molecular testing, RT-PCR, from nasopharyngeal 
swabs, attended and hospitalized between March 
6th and April 30th of 2020, in the Hospital Rebagliati. 
Only patients with confirmed pulmonary lesions by 
CT scan and oxygen saturation level below 93% 
were hospitalized due to a higher demand for health 
care services in Peruvian public hospitals. There 
were excluded patients transferred to other health 
centers and patients that arrive without vital signs. 
We obtained demographic data (age, gender), 
cardiovascular risk factors (hypertension, Diabetes, 
obesity), history of previous cardiovascular 
disease, time of symptoms, symptoms and signs 
during emergency arrival, prevalence of myocardial 
injury, Electrocardiographic (ECG) findings, time of 
hospital ization, prevalence of mechanical 
ventilation and evolution, from electronic clinical 
report of patients during hospitalization.
A twelve-lead ECG was recorded and evolution of 
troponin values were registered, considering the 
highest value of troponin during the evolution, and 
the diagnosis of myocardial injury if this value 
exceeds 99th percentile of the laboratory range 
validated in the hospital.
We used SPSS 24.0 for statistical analysis that 
includes descriptive, bivariate analysis, and 
multivariate analysis (binary logistic regression). A 
p-value of less than 0.05 was considered 
statistically significant (95% confidence level).
The project was authorized for the emergency 
department and the Ethics and investigation 
committee for COVID-19 in EsSalud. The principle 
of confidentiality was guaranteed. Informed consent 
was not obtained because the source document 
was secondary (an electronic clinical record), and 
there was not any intervention for the patient. 
Results
One hundred six hospitalized patients were 
evaluated.  47 (44.34%) had more than 65 years of 
age and  81 (76.4%) were of male gender (Table 1). 
Cardiovascular risk factors among the study 
population were hypertension (46.2%), diabetes 
(28.3%), and obesity (28.3%). Sixteen patients 
(6.76%) report a previous cardiovascular disease 
(15.09%).
They arrived in the emergency room with more than 
seven days of symptoms: 7.35 (SD 3.53). 54.71% 
with more than seven days (Table 1).
Table 1. Clinical , demographical and 




<30 years 3 2.83
30-64 years 56 52.83
65-84 years 39 36.79
?85 years 8 7.55
Gender distribution
Male  81 76.4
Female 25 23.6




Previous history of cardiovascular 
disease 16 15.1
Time of symptoms at arrival
Less than 3 days 16 15.1
From 3 to 7 days 32 30.2
More than 7 days 58 54.7
The most frequent signs and symptoms during 
emergency arrival (Figure 1) were dyspnea 
(82.07%), tachycardia (35.8%), and higher levels of 
blood pressure (17.9%). Myocardial injury was 
found in 40 of 79 patients tested (50.6%). The 
median value of troponin value was 0.033 (IQR 
0.047).
Figure 1. Clinical findings at the ER income
ECG finding N %
Normal ECG 22 55
Arrythmia 11 27.5
-atrial fibrillation 4 10
-sinus bradycardia 2 5
-sinus tachycardia 1 2.5
-First degree AV block 2 5
-Third degree AV block 1 2.5
-Ventricular extrasystolia 1 2.5
Left ventricular hypertrophy 3 7.5
Acute ischemia 3 7.5
In 40 patients, 12-lead ECG recorded was obtained. 
22 (55%) had an ECG without specific alterations. In 
the rest of the patients, some arrhythmias and other 
ECG changes were documented (Table 2).
Table 2. ECG findings
The median of hospitalization was eight days (IQR 
12.25). In 64.15% of cases, the time of admission 
was higher than seven days, and in 17 patients 
(16.04%) was more top than 30 days. 22 (20.75%) 
patients entered to invasive mechanical ventilation. 
Fifty-six patients died, which corresponds to a 
mortality rate of 52.8% (Figure 2). Mortality 
associated factors  were age more than 65 years, 
myocardial injury, mechanical ventilation, and 
arterial hypertension were associated with 
statistical differences in bivariate analysis. In the 
mul t i var ia te  ana lys is ,  we found ar te r ia l 
hypertension, myocardial injury, and mechanical 
ventilation as associated factors (Table 3).
Discussion
The present report describes cardiovascular risk 
factors and some clinical, laboratory, and electro-
cardiography findings in a group of patients 
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cular risk factors and fatal outcomes (26).
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similar to CDC and Italian reports (from the 
Lombardy region) for arterial hypertension (46.2%) 
and higher in comparison with reports of Chinese 
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Figure 2. Survival rates of the patients by time
Table 3. Mortality associated factors
ORc=crude odds ratio (bivariate analysis); ORa=adjusted odds ratio (multivariate analysis).
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Variable ORc 95%CI ORa 95%CI
Arterial hypertension 4.28 1.880-9.730 1.343 1.089-1.667
Myocardial injury 4.7 1.810-12.210 1.303 1.031-1.642
Mechanical ventilation 5.44 1.690-17.470 1.262 1.034-1.665
Age more than 65 years 2.76 1.220-6.200 1.07 0.848-1.354
Obesity 1.24 0.520-2.900 1.055 0.848-1.323
Male gender 1.59 0.640-3.920 0.959 0.747-1.217
Diabetes 0.85 0.360-1.980 0.879 0.691-1.097
where a prevalence of 27.3% was found (13). At the 
national level, the prevalence of Diabetes in Peru 
was reported in ranges between 5 and 7% (14)
Hypertension and cardiovascular disease were 
associated with a higher risk of severity and 
mortality in patients infected with COVID-19 
because their conditions could damage the vas-
cular structure, and it is more likely to develop into 
critical disease during the infection. Moreover, 
patients with chronic cardiovascular disease are 
more likely to be infected due to their weakened 
heart function and low immunity, developing severe 
disease patterns (20-22).
Recent studies indicate multi-organ tropism of 
SARS-CoV-2, including heart, vascular system, and 
the circulation, which is speculated to influence the 
course of the disease as well as aggravate 
preexisting conditions. The increased-myocardial 
expression of ACE2 in patients with cardiovascular 
disease and COVID-19 has been suggested as a 
possible mechanism of myocardial cell invasion and 
injury levels to worse outcomes (21).
Myocardial injury is manifested as an elevation of 
troponin levels above the 99th percentile of superior 
normality level and is associated with an increase in 
mortality. It could be presented with electrocar-
diographic and echocardiographic changes. In 
some cases, could evolution to a fulminant 
myocarditis (1,2,6,15).
We found a prevalence of myocardial injury of 
50.6%, superior to report in the hospitalized 
population (7-17%), and ICU population (22-31%) 
(1,12,15). Moreover, in a recent metanalysis of 26 
clinical studies with 11,685 patients, the prevalence 
was 20% (17). However, in subpopulations of 
severe or critical COVID-19 cases, similar to the 
cases described in this report, the prevalence could 
be much higher: from 65.2% and 80% (21).
In a retrospective study of 191 patients, older age 
was recognized as a risk factor of mortality and has 
been reported as a significant predictor of mortality 
in SARS and MERS, probably because of age-
dependent defects in T-cell and B-cell function and 
the excess production of type 2 cytokines that could 
amplify viral replication and prologs proinflam-
matory responses (23). Other factors like the 
presence of comorbidities in older patients (particu-
larly hypertension)  are believed to be risk factors 
for severe disease and death for SARS-Cov-2 
infection. 
Moreover, in deceased patients, higher levels of 
cardiac troponins were associated with poorer 
outcomes and mortality, as was described in 
several reports (16,24). In a recent study in Bolivia, 
the mortality rate was 5.6%, but age and hyperten-
sion (OR=3.284, 95%CI 1.276-6.291) were the 
main associated factors with the fatal outcomes, 
very similar to our current findings for this factor 
(Table 2) (26).
Previously a preliminary description of patients with 
severe COVID-19 was reported in our hospital. This 
study described 17 patients, 5 of them died. Authors 
identified advanced age (6), arterial hypertension 
(4), and obesity (3), as the main observed risk 
factors in these patients (27).
This study is an exploratory case-series without 
randomization, that obtain data from electronic 
clinical reports. We did not register body mass 
index, and there was not a formal criterion to get 
troponin dosage or ECG recording in every patient 
hospitalized for COVID-19. Although there is an 
essential number of patients in this region, and 
describe the cardiovascular findings associated 
with this disease (27,28).
Conclusions
Dyspnea, tachycardia, and a higher level of blood 
pressure at admission were the most frequent 
clinical manifestations. We found myocardial injury 
in almost half of the total population and ECG 
changes in more than a fourth of our population. On 
the other hand, arterial hypertension, the use of 
mechanical ventilation, and myocardial injury were 
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Intervención educativa para la higiene dental en preescolares de contextos vulnerables: 
autoeficacia, intención y control percibido por padres e hijos
Educational intervention for dental hygiene in preschool children from vulnerable contexts: 
self-efficacy, intention and perceived control by parents and children
1,a 1,bJudith Cavazos-Arroyo , Martha L. Gaeta-González
Resumen
La caries dental es una de las enfermedades crónicas más prevalentes en la infancia temprana con 
repercusiones en la calidad de vida de los menores. Esta etapa constituye una oportunidad para que los 
niños adquieran hábitos y control de su higiene oral, sobre todo en contextos de vulnerabilidad social. 
Objetivo: Analizar las creencias de los padres sobre su capacidad para apoyar a sus hijos en el desarrollo de 
hábitos de higiene dental y las creencias de los menores sobre la adquisición de estos hábitos antes y al 
término de un programa de desarrollo de hábitos de higiene dental. Métodos: Se estableció un diseño cuasi-
experimental con pre-test y pos-test a dos grupos: padres de familia y sus hijos en edad pre-escolar 
participantes de un programa educativo enfocado al desarrollo de hábitos de higiene dental en México. Se 
compararon hábitos, autoeficacia, intención y control sobre higiene bucal, mediante la prueba t pareada. 
Resultados: Se encontró que la intención de los padres de tomar acciones sobre la higiene bucal de su 
hijo/a fue mayor que los comportamientos llevados a cabo durante la intervención. Después del programa, 
los padres redujeron la supervisión del cepillado de su hijo/hija y los niños presentaron mejor 
comportamiento del cuidado dental. Conclusión: Se evidenció la relevancia de realizar un trabajo de 
intervención continuado a largo plazo, a fin de potenciar que los infantes mantengan control de su higiene 
bucal.
Palabras clave: higiene dental, autoeficacia, desarrollo infantil, interacción padres-hijos (fuente: DeCS)..
Abstract
Dental caries is one of the most prevalent chronic illnesses in early childhood, with repercussions on minors' 
quality of life. This vital stage constitutes an opportunity for children to acquire oral hygiene habits and control 
over them, especially in social vulnerability contexts. Objective: To analyze parents' beliefs about their ability 
to support their children in developing dental hygiene habits and children's beliefs about the acquisition of 
these habits before and after completing a dental hygiene development program. We established a quasi-
experimental design with pre-test and post-test for two groups: parents and their preschool-age children 
participating in an educational program focused on developing dental hygiene habits in Mexico. We 
compared the habits, self-efficacy, intention and control on oral hygiene, through a paired t-test analysis. 
Results: The findings showed that the parents' intention to take action on their child's oral hygiene was higher 
than the behaviors carried out during the intervention. After the program, parents reduced their child's 
brushing supervision, and the children exhibited increased dental care behavior. Conclusions: We 
emphasize the relevance of carrying out continuous intervention work in the long term to empower children to 
control their oral health.
Keyword: oral hygiene, self-efficacy, child development, parent-child relations (source: MeSH)
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Introducción
La salud bucodental es esencial para la salud 
general, el bienestar y la calidad de vida personal 
(1). Desafortunadamente, las enfermedades 
bucodentales representan una de las principales 
afectaciones de salud entre la población, que se 
presentan desde los primeros años de vida, siendo 
la caries dental una de las enfermedades crónicas 
más prevalentes en la infancia temprana (2). La 
falta de higiene dental se encuentra entre las 
principales causas de su prevalencia, principal-
mente en poblaciones en desventaja social (3, 4).
De no prevenirse, la caries dental genera 
repercusiones en el desarrollo físico, cognitivo y 
social de los niños (5). Se recomienda su atención 
preventiva desde la infancia temprana -antes de los 
seis años (2), al ser una edad crítica para adquirir 
hábitos y control de la higiene oral (4). La 
implementación de intervenciones educativas de 
manera sostenida requiere (6): empoderar a los 
padres y, a través de ellos inculcar y reforzar 
hábitos de autocuidado en sus hijos. Los padres 
proporcionan modelos y orientaciones constantes a 
los menores, por lo que el apoyo y guía de los 
padres es determinante para que los menores 
logren un sentido de autoeficacia para su higiene 
dental, tengan la intención y el control de la práctica 
y generen hábitos de higiene bucal (8).
La autoeficacia refiere a la creencia personal sobre 
la propia capacidad para realizar acciones 
específicas y lograr resultados esperados (13). En 
el ámbito de la salud ha demostrado tener un papel 
mediador hacia acciones de higiene bucal en 
adultos (12). La autoeficacia paterna involucra la 
creencia de la propia capacidad para el cuidado 
dental de los hijos (7), que repercute en la 
disminución y prevención de la lesión de caries 
dental de los niños, a partir de una adecuada 
preparación de los padres.
Para el autocuidado bucal, las personas deben 
tener la intención del comportamiento y la 
determinación para persistir ante las dificultades, lo 
cual demanda control del propio comportamiento 
(11), a partir de la conciencia y dominio de las 
habilidades y las capacidades personales (12). El 
ejemplo y la supervisión de los padres son clave 
para que los menores desarrollen la intención de 
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